QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-neutral-on-aadi-bioscience

HC Wainwright & Co. analyst Robert Burns reiterates Aadi Bioscience (NASDAQ:AADI) with a Neutral.

 aadi-bioscience-q1-2024-gaap-eps-068-misses-065-estimate-sales-5353m-miss-6454m-estimate

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0...

 reported-sunday-aadi-bioscience-presented-new-subgroup-analysis-of-patients-with-advanced-malignant-pecoma-of-gynecologic-origin-treated-with-nab-sirolimus-at-society-of-gynecologic-oncology

Subgroup experienced efficacy and safety consistent with overall study population Advanced malignant PEComa tumors of gyneco...

 aadi-bioscience-q4-gaap-eps-060-beats-065-estimate-sales-633m-beat-629m-estimate

Aadi Bioscience (NASDAQ:AADI) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.6...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 aadi-bioscience-earnings-preview
Aadi Bioscience Earnings Preview
03/12/2024 17:01:21

 why-bitdeer-technologies-shares-are-trading-higher-by-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported prelimina...

 why-biovie-shares-are-trading-lower-by-around-42-here-are-20-stocks-moving-premarket

Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public ...

 aadi-bioscience-announces-publication-of-long-term-efficacy-and-safety-data-further-supporting-fyarro-for-the-treatment-of-malignant-pecoma

After 3 years of follow-up in AMPECT trial, confirmed clinically meaningful overall response rate, including multiple patients ...

 aadi-bioscience-announces-poster-presentations-at-the-2024-american-society-of-clinical-oncology-genitourinary-cancers-symposium

Real-world genomic analysis highlights unmet medical need in GU cancer patients with TSC1/2 inactivating alterations

 top-3-health-care-stocks-that-are-preparing-to-pump-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 cancer-player-aadi-bioscience-downgraded-analyst-highlights-worse-than-expected-response-rates

Friday, Aadi Bioscience Inc (NASDAQ: AADI) released results from a planned interim analysis on the first third of participants ...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

 dow-edges-higher-darden-restaurants-earnings-top-views

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 70 points on Friday. The Dow traded...

 piper-sandler-maintains-overweight-on-aadi-bioscience-lowers-price-target-to-5

Piper Sandler analyst Joseph Catanzaro maintains Aadi Bioscience (NASDAQ:AADI) with a Overweight and lowers the price target...

 us-stocks-mixed-costco-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 75 points on Friday. The Dow traded down 0.20% ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION